NDC 70518-0786-2 - Losartan Potassium and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-0786
- Requested NDC
- 70518-0786-2
- Package NDCs from labels
- 70518-0786-0, 70518-0786-2, 70518-0786-1
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium and Hydrochlorothiazide - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-02-13 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | e31bd548-29ae-419a-831a-80ebb26e042f | 2024-06-26 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lancome Paris Teint Idole Ultra Wear Breathable Coverage Foundation Reno Broad Spectrum SPF 25 Sunscreen | OCTINOXATE AND TITANIUM DIOXIDE | SICOS ET CIE | 066a0951-2e7e-40c0-8035-4d708a32f16c | 2024-06-26 | Warnings | 15FIX9V2JP |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 01f1f478-5493-439f-9b99-f4f82023781c | 2024-06-26 | Warnings, Adverse reactions | 0J48LPH2TH |
| Yves Saint Laurent All Hours Foundation Broad Spectrum SPF 30 Sunscreen Luminous Matte Foundation | OCTINOXATE AND TITANIUM DIOXIDE | SICOS ET CIE | 66a91768-6012-485a-b569-a293ea6d4880 | 2024-06-24 | Warnings | 15FIX9V2JP |
| Yves Saint Laurent All Hours Foundation Broad Spectrum SPF 30 Sunscreen Luminous Matte Foundation | OCTINOXATE AND TITANIUM DIOXIDE | L'Oreal USA Products Inc | 43539766-2e70-4b42-b64b-1d30367b2eb9 | 2024-06-24 | Warnings | 15FIX9V2JP |
| Exel Clarifying Line SPF 50 | OCTINOXATE, OCTOCRYLENE, OXYBENZONE, TATANIUM DIOXIDE | Biocosmetica Exel Argentina SRL | e65a68f6-d1b7-4cbf-a3f8-5cc04036221a | 2024-06-23 | Warnings | 15FIX9V2JP |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 681dfb5c-fc5c-427e-81f6-4b4e934978a2 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 9c0809dc-cbdd-1a33-e053-2995a90a4825 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 9f1c20aa-2028-412d-e053-2995a90a1368 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | a11075f1-f7d0-0c3d-e053-2995a90a0c9d | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | a111cb8f-a100-a05d-e053-2995a90a020c | 2024-06-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | a1123700-f4c7-2b62-e053-2a95a90a87d6 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 9130921b-02f0-82d6-e053-2995a90a9c0a | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 91305ca4-7d56-2052-e053-2995a90a5d61 | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 97a50b38-f5b3-0a96-e053-2995a90a345f | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 8c2b3412-254b-8fa9-e053-2a95a90a7dc6 | 2024-06-18 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Protectif Fair Tint | ZINC OXIDE AND TITANIUM DIOXIDE | Derma Research Group Inc. | 1a8c8804-1d6b-b5a5-e063-6394a90a1260 | 2024-06-18 | Warnings | 15FIX9V2JP |
| benazepril hydrochloride and hydrochlorothiazide | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | f4120568-dd9b-47a5-bd44-4de6ed343bbe | 2024-06-18 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | c5bc7c55-b50c-4e61-ad1f-5ebb607c262f | 2024-06-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Protectif Untinted | ZINC OXIDE AND TITANIUM DIOXIDE | Derma Research Group Inc. | 1acd3f09-87f2-75e4-e063-6394a90a0cd9 | 2024-06-13 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.